AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
4,165,796
Share change
+20,802
Total reported value
$31,242,000
Price per share
$7.50
Number of holders
21
Value change
+$171,565
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q4 2014

As of 31 Dec 2014, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,165,796 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, Visium Asset Management, LP, Cormorant Asset Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, HIGHLAND CAPITAL MANAGEMENT LP, ROYCE & ASSOCIATES LLC, PERCEPTIVE ADVISORS LLC, and PUTNAM INVESTMENTS LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.